Bionano Genomics (BNGO) EBITDA US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
EBITDA, bln rub ? -73.9 -120.3 -213.6 -97.5 -16.3   -23.3  
Changes by years, y/y, % +108% +63% +78% -54% -83%     -14.5%

Bionano Genomics. EBITDA US GAAP, bln rub

Bionano Genomics. EBITDA US GAAP, changes, %

Bionano Genomics. EBITDA US GAAP, sum by quarters, bln rub

Bionano Genomics (BNGO) EBITDA US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
EBITDA, bln rub ? -5.98 -4.45 -5.99 -5.44 -5.86   -23.3
Changes by years, y/y, % -75% -65% -84% -69% -2%    
Changes by quarters, q/q, % -66% -26% +35% -9% +8%    

Bionano Genomics. EBITDA US GAAP, bln rub

Bionano Genomics. EBITDA US GAAP, changes, y/y, %

Bionano Genomics. EBITDA US GAAP, changes, q/q, %